University of Houston jump-starts fall semester with autonomous, zero-emission food delivery robots

beep, beep

Through a partnership with Grubhub and Starship Technologies, UH now has fully autonomous delivery robots available for cross-campus food deliveries.

It's not just students moving in at the University of Houston's campus this week — a fleet of food delivery robots will be settling in as well.

Through a partnership with Grubhub and Starship Technologies, UH now has fully autonomous delivery robots available for cross-campus food deliveries.

“Coming off of a strong 2023-2024 school year, I’m very proud that we’re continuing to significantly grow our campus footprint and see such strong adoption of our additional services and solutions with our partners," Rob DelaCruz, vice president and general manager of Grubhub Campus, says in a statement. "We see further opportunity in the campus space, and we’re proud to play a role in how students and faculty dine. Our technology allows our partners to operate their dining facilities more efficiently by providing them with the ability to get diners through lines faster and provide a broad range of pickup and delivery innovations.”

Robot-delivered food orders can be placed via the Grubhub app, which also features an interactive map where users can watch as their food traverses campus toward them. Grubhub reports that the robot deliveries also represent a more sustainable food delivery option.

San Francisco-based Starship Technologies previously launched 30 of its robots on the UH campus in 2019. Grubhub and Starship originally teamed up last year with five universities and plans to expand to 25 schools and 2,000 robots. This fall, the organizations have expanded to over 50 schools.

“Grubhub has been an exceptional partner as we expand our reach to more schools and elevate the dining experience for universities nationwide," Chris Neider, vice president of business development at Starship Technologies, adds. Their support and collaboration have been instrumental in our growth, allowing us to deliver innovative and convenient solutions to students and campus communities across the country.”

According to Starship, its zero-emission robots cross roads over 150,000 times a day and have completed nearly seven million commercial deliveries globally, which is reportedly more than any other autonomous delivery provider.

From Your Site Articles
Coming soon — autonomous food delivery on Uber Eats. Photo courtesy of Nuro and Uber

Tech company inks 10-year deal with Uber to provide self-driving delivery service in Houston

automatic autos

Houstonians will soon be able to get completely autonomous delivery of their dinners, groceries, and more thanks to a new 10-year partnership.

Uber Technologies, Inc. and Nuro have cut a deal that will provide autonomous, electric vehicles for food deliveries in Houston and Mountain View, California, beginning his fall, according to a news release. A Bay Area expansion will follow, but Houston's no stranger to Nuro-powered deliveries. California-based Nuro has launched five delivery pilot programs in Houston since 2019 with partners Kroger, Walmart, CVS, Domino's, and FedEx.

With this new partnership, users will have access to meals, groceries, and other goods available on the Uber Eats platform — as well as the opportunity to support local businesses.

“Nuro and Uber share a vision in which technology can make everyday life just a little bit easier,” says Noah Zych, global head of autonomous mobility and delivery at Uber, in the release. “Nuro’s distinctive autonomous vehicles are a great match for the Uber platform, and this partnership will bring a compelling combination of innovation alongside the convenience, affordability and reliability our customers and merchants have come to expect.”

Nuro, which recently closed a $600 million series D round just under a year ago, is reportedly the first company to operate fully autonomous vehicles in three states —Arizona, California, and Texas.

“Our partnership with Uber underscores Nuro’s track record of partnering with the world’s leading brands to make autonomous delivery a seamless experience,” says Cosimo Leipold, head of partnerships at Nuro, in the release. “With our unique autonomous delivery vehicles and Uber’s phenomenal scale and reach, we can expand food delivery options from your favorite local mom-and-pop restaurants all the way to nationwide chains.”

The company tapped Houston as its first full-scale operational city. Nuro previously told InnovationMap that was because the city offered a wide range of variation in the infrastructure across Houston's neighborhoods.

"Houston is our first full-scale operations city," Sola Lawal, product operations manager in Houston, told InnovationMap in January 2020. "All eyes at Nuro are focused on Houston."

Autonomous Uber Eats coming soon — thanks to Nuro. Photo courtesy of Nuro and Uber

The University of Houston campus has 30 new members — self-driving, food-delivering robots. Photo courtesy of UH

University of Houston rolls out food delivery robots

on the move

For a small delivery fee of $1.99, students, faculty, and staff across the University of Houston campus can now get their lunch delivered by self-driving robots.

Thirty of San Francisco-based Starship Technologies' autonomous delivery robots now roam the campus thanks to a partnership with New York-based Chartwells Higher Education. The Houston campus is the first to roll out robotic food deliveries.

"This revolutionary delivery method will make it more convenient for the campus community to take advantage of our diverse dining program from anywhere on campus while expanding the hours of operation," says Emily Messa, associate vice president for administration, in a news release. "By opening our campus to this innovative service, which is paid for by the customers, the university didn't have to spend any money purchasing the technology, yet we're enhancing our food delivery capabilities."

Through the Starship Deliveries app, which is available on iOS and Android, users can select from 11 dining institutions and then identify where they are on campus. The platform allows the user to track the progress, and the device can hold up to 20 lbs of food and has the space for about three shopping bags of groceries.

"This increases our capacity to reach more customers, and I expect the robots will quickly become part of campus life," says David Riddle, Chartwells resident district manager, in a news release. (Chartwells manages UH Dining). "Robot delivery will also grow opportunities for UH Dining employees by increasing service hours and growing sales. It has also created additional jobs for students dedicated specifically to servicing the autonomous robots. It's an important advancement for foodservice at UH."

Using machine learning, artificial intelligence and sensors, the company's robots have driven over 350,000 miles and completed over 150,000 deliveries. The Starship robots "can cross streets, climb curbs, travel at night and operate in both rain and snow," per the release.

"Robotic delivery is affordable, convenient and environmentally friendly," says Ryan Tuohy, senior vice president of business development for Starship, in the release. "We're excited to start offering students, staff and faculty at Houston delivery within minutes when they need it most."

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

Houston digital health platform Koda lands strategic investment

money moves

Houston-based advance care planning platform Koda Health has added another investor to the lineup.

The company secured a strategic investment for an undisclosed amount from UPMC Enterprises, the commercialization arm of the University of Pittsburgh Medical Center. The funding is part of Koda's oversubscribed series A funding round that closed in October, according to a release.

"UPMC Enterprises’ investment is a meaningful signal, not just to Koda, but to the broader market," Dr. Desh Mohan, chief medical officer and co-founder of Koda Health, said in the news release. "It validates that health systems are ready to invest in infrastructure that makes advance care planning work the way it should: proactively, at scale, and with the human support that these conversations require. Having UPMC Enterprises as a strategic investor puts us in a unique position to prove what's possible."

Koda has raised $14 million to date, according to a representative from the company. Its series A round was led by Evidenced, with participation from Mudita Venture Partners, Techstars and the Texas Medical Center last year. At the time, the company said the funding would allow it to scale operations and expand engineering, clinical strategy and customer success. The company described the round as a "pivotal moment," as it had secured investments from influential leaders in the healthcare and venture capital space.

Koda Health, which was born out of the TMC's Biodesign Fellowship in 2020, saw major growth last year, as well, and now supports more than 1 million patients nationwide through partnerships with Cigna Healthcare, Privia Health, Guidehealth, Sentara, UPMC and Memorial Hermann Health System.

The company integrated its end-of-life care planning platform with Dallas-based Guidehealth in April 2025 and with Epic Systems in July 2025. It also won the 2025 Houston Innovation Award in the Health Tech Business category. Read more here.

UH med school gets $2M gift and more top Houston innovation news

Trending Topics

Editor's note: The top Houston innovation news of the month is full of fresh funding, with two Texas medical schools receiving major gifts — one of historic proportions. Below are the five most-read InnovationMap headlines from April 16-30, 2026.

UH med school granted $2M gift to offer student scholarships

A new scholarship endowment aims to support students in the University of Houston’s recently established medical school. The University of Houston’s Tilman J. Fertitta Family College of Medicine received a planned estate gift commitment estimated at $2.1 million to establish the Bob Diehl and Teresa Evans Diehl Scholarship Endowment. The scholarship will assist full-time medical students who demonstrate financial need and meet academic standards. Continue reading.

How Houston innovators played a role in the historic Artemis II splashdown

Research from Rice University played a critical role in the safe return of U.S. astronauts aboard NASA’s Artemis II mission this month. Rice mechanical engineer Tayfun E. Tezduyar and longtime collaborator Kenji Takizawa developed a key computational parachute fluid-structure interaction (FSI) analysis system that proved vital in NASA’s Orion capsule’s descent into the Pacific Ocean. The FSI system, originally developed in 2013 alongside NASA Johnson Space Center, was critical in Orion’s three-parachute design, which slowed the capsule as it returned to Earth, according to Rice. Continue reading.

Baylor scientist lands $2M grant to explore links between viruses and Alzheimer’s

A Baylor College of Medicine scientist will begin exploring the possible link between Alzheimer’s disease and viral infections thanks to a $2 million grant awarded in March. Dr. Ryan S. Dhindsa hypothesizes that Alzheimer’s may have some link to previous viral infections contracted by the patient. To study this intriguing possibility, the American Brain Foundation has gifted him the Cure One, Cure Many award in neuroinflammation. Continue reading.

New UT Austin med center, anchored by MD Anderson, gets historic gift

A donation announced April 21 breaks a major record at the University of Texas at Austin. Michael and Susan Dell are now UT Austin's first supporters to give $1 billion. In response, the university will create the UT Dell Campus for Advanced Research and the UT Dell Medical Center to "advance human health," per a press release. Continue reading.

Houston VC funding surged nearly 50% in Q1 2026, report says

Houston saw a jump in VC funding in Q1 2026, fueled by several major investments in clean energy startups. Image via Getty Images

First-quarter venture capital funding for Houston-area startups climbed nearly 50 percent compared to the same time last year, according to the PitchBook-NVCA Venture Monitor. In Q1 2026, Houston-area startups raised $532.3 million, a 49 percent jump from $320.2 million in Q1 2025, according to the PitchBook-NVCA Venture Monitor. However, the Q1 total fell 23 percent from the $671.05 million raised in Q4 2025. Continue reading.

New 'living pharmacy' biotech company launches out of Rice venture studio

fighting cancer

Rice University’s biotech venture studio RBL LLC has launched a new “living pharmacy” company, Duracyte, designed to make cancer treatment easier on patients.

Backed by an up to $45 million Advanced Research Projects Agency for Health (ARPA-H) award, Duracyte aims to commercialize implantable biohybrid pharmacy devices that are designed to produce therapeutic proteins inside the human body around the clock, replacing the need for regular injections and infusions for some cancer patients.

The company’s main platform is its Hybrid Advanced Molecular Manufacturing Regulator (HAMMR), a rechargeable, implantable device that can sense biological signals, monitor tumor environments and adjust therapeutic output in real time. HAMMR has wireless communication capabilities, which allow patients and clinicians to remotely monitor results through an app every five minutes and make changes to treatment plans without a hosptial visit. Additionally, the device can generate its own oxygen supply, which is key for the therapeutic cells’ survival.

“Biologic medicines such as monoclonal antibodies, cytokines and metabolic regulators already account for a significant share of modern therapeutics, but the way we deliver them today often requires frequent injections or infusions that can be demanding for patients and lead to inconsistent drug levels,” Daniel Anderson, MIT professor and co-founder of Duracyte, said in a news release. “Our vision is to enable a continuous, stable therapy by producing these medicines directly inside the body, which could improve treatment consistency, reduce side effects and ultimately transform how biologic therapies are delivered across many diseases.”

Duracyte’s first clinical trial is slated to begin by the end of 2026 and will focus on recurrent ovarian cancer. The Phase I study will build upon existing work on encapsulated cytokine pharmacy technology, and the company hopes that within a few years this treatment can reach clinical application.

The development of Duracyte is supported by ARPA-H's Targeted Hybrid Oncotherapeutic Regulation (THOR) project, which supports a multidisciplinary research consortium co-led by Omid Veiseh, a professor of bioengineering at Rice. The consortium also includes others at Rice, The University of Texas MD Anderson Cancer Center, Stanford University, Carnegie Mellon University, Northwestern University and the University of Houston, plus industry collaborators like Chicago-based CellTrans.

“What we are building is the culmination of years of progress in cell engineering, biomaterials and implantable device technology,” Veiseh added in the release. “By combining these advances with real-time sensing and adaptive drug delivery, we are working with the support of RBL to create a true ‘living pharmacy’ that can deliver continuous, precisely controlled biologic therapies and fundamentally change how these treatments reach patients.”

RBL launched in 2024 and is based out of Houston’s Texas Medical Center Helix Park. Duracyte is the third company launched by RBL, including Sentinel BioTherapeutics, a clinical-stage immunotherapy company developing localized cytokine therapies for solid tumors, and SteerBio, a regenerative medicine company targeting lymphedema.

“Duracyte exemplifies the kind of breakthrough that Houston’s ecosystem is built to produce,” Paul Wotton, managing partner of RBL LLC and co-founder of Duracyte, added in the release. “With world-class clinical infrastructure, exceptional engineering talent and initiatives like the Texas Biotech Task Force driving alignment across industry, investment and talent, this region is uniquely positioned to move the most ambitious ideas in medicine from concept to patient, faster than anywhere else.”

View All Listings